Short answer
ORASURE TECHNOLOGIES INC (OSUR) filed its Q1 2026 10-Q quarterly report on May 8, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $28M (down 6.7% year over year) with net income of −$22M.
Q1 2026 key financials · XBRL
- Revenue
- $28M
- −6.7% YoY
- Net income
- −$22M
- −39.5% YoY
- Operating margin
- -83.3%
- Gross margin
- 42.3%
- EPS (diluted)
- −$0.32
- −52.4% YoY
Source: XBRL data from the ORASURE TECHNOLOGIES INC (OSUR) Q1 2026 10-Q on SEC EDGAR. USD.
ORASURE TECHNOLOGIES INC Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $27.9M, down 7% YoY from $29.9M
- Gross margin 42.3% vs 41.1% YoY; operating loss $23.3M vs $17.8M
- Best performer: non-product revenue $1.5M, up 66% YoY; worst: risk assessment $0 vs $1.4M
- Cash $177.0M vs $199.3M at December 31; operating cash use $13.9M
- Capital deployment: $5.0M share repurchases and $0.9M property-equipment purchases
- Outlook: cash sufficient for next twelve months; headwinds include clinical testing, regulatory costs, acquisitions, and market acceptance
Risk Factors
- No material changes to 10-K risk factors for year ended December 31, 2025
- No newly added risk factor or quarter-specific trigger disclosed
- Regulatory and compliance risks carried forward without quarterly updates
- Operational and competitive risks unchanged from the March 9, 2026 10-K
- Financial risks unchanged; $19,960,003 remained available under the repurchase program at March 31, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ORASURE TECHNOLOGIES INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.